Genzyme Corporate Research Search Genzyme Websites
PatientsHealth Care ProfessionalsPayors
Thyrogen
Patient Overview
Newly Diagnosed
Follow-up
What To Expect
Testing
Role of Thyrogen
Thyroid Cancer Recurrence
Reimbursement
Resources
Product Information (PDF)

Thyroid Cancer Recurrence

If you are a thyroid cancer survivor, it is not uncommon to have concerns about recurrence. As with all cancers, recurrence can happen after successful therapy for thyroid cancer, even if you’ve been disease-free for years. In fact, up to 30% of well-differentiated thyroid cancer patients experience a recurrence, two thirds of which occur within the first 10 years after therapy.

However, recurrences may take place decades after initial thyroid cancer therapy. As with initial diagnoses of well-differentiated thyroid cancer, the prognosis is improved if the recurrence is caught early, when the tumor is small and localized. These are both good reasons why it’s so important to keep up with routine checkups!

If you have a recurrence, it may either be local (in the thyroid area) or metastatic (somewhere else in your body).

Local recurrence

Your doctor may suspect a recurrence in the thyroid area, based on thyroglobulin (Tg) testing, a whole body scan (WBS), ultrasound and/or a biopsy. If a recurrence is confirmed, you may be treated with further surgery or with radioactive iodine (RAI) therapy.

Metastatic recurrence

If your cancer comes back outside the thyroid area, it is said to have “metastasized.” When thyroid cancer metastasizes, it may appear in the central nervous system, in the lymph nodes, in areas of the lungs or bones, or in the neck.

Even though the cancer has metastasized, the cancer cells are still thyroid cells. This means that, after testing to confirm the recurrence, metastasized thyroid cancer can sometimes be treated the way the primary cancer was — with surgery and/or RAI therapy.

After treating a recurrence, you’ll probably be monitored more frequently for the first few years after therapy.

Managing recurrent thyroid cancer

Recurrent thyroid cancer is often treated in much the same way as the original cancer. Your doctor’s recommended choice of treatment depends on the type of thyroid cancer you have, your previous treatment, and where the cancer comes back — whether it is localized or metastatic. To read more about common treatment options, please visit the Newly Diagnosed section of this site.


Safety Information
Thyrogen® (thyrotropin alfa for injection) is used in combination with other tests to detect recurring or leftover thyroid cancer cells in patients with a history of certain types of thyroid cancer. Thyrogen is injected in a muscle, and is available only by prescription. The most common side effects reported in clinical studies were nausea, headache, weakness & vomiting. When using Thyrogen, there is a risk that thyroid cancer cells may not be detected and diagnosis of recurring cancer may be missed. If you think that Thyrogen may be right for you, or if you have any problems with the use of Thyrogen, please contact your doctor. To learn more, please see full product information (PDF), contact Genzyme toll free at 1-88-THYROGEN (1-888-497-6436).
Search Thyrogen
Keyword: 
Search In: 
 
Highlight

Take Action Early

If you or someone you know has Thyroid Cancer, the more you know about this disease and its management the better. Here are some additional resources for patients.

Resources
Related Links
Testing Schedule
Patient Education Materials
Request Materials
Events Calendar
Low-iodine Diet
Glossary
Contact Information
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142
888 497 6436
617 768 8050
Contact Genzyme



 
Thyrogen Terms and Conditions of Use | Privacy Policy | This site is intended for United States residents only © 2003-2008 Genzyme Corporation. All rights reserved. Genzyme